These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 14003718

  • 1. [Mouse protection studies with zymosan vaccines and properdin sera. Contribution to unspecified immunity (resistance)].
    ZIMMERMANN G.
    Acta Biol Med Ger; 1962; 9():412-27. PubMed ID: 14003718
    [No Abstract] [Full Text] [Related]

  • 2. [THE ROLE OF THE PROPERDIN SYSTEM IN NON-SPECIFIC IMMUNITY].
    HOSHINO A.
    Nihon Naika Gakkai Zasshi; 1963 Dec 10; 52():1023-40. PubMed ID: 14158037
    [No Abstract] [Full Text] [Related]

  • 3. The properdin system and immunity. III. The zymosan assay of properdin.
    PILLEMER L, BLUM L, LEPOW IH, WURZ L, TODD EW.
    J Exp Med; 1956 Jan 01; 103(1):1-13. PubMed ID: 13278451
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF, WEDGWOOD RJ, PILLEMER L.
    J Lab Clin Med; 1961 Feb 01; 57():185-98. PubMed ID: 13714488
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Bactericidal activity of normal and low-properdin sera and of properdin-zymosan complexes].
    SZEMERE G.
    Kiserl Orvostud; 1963 Feb 01; 15():58-61. PubMed ID: 13979914
    [No Abstract] [Full Text] [Related]

  • 9. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
    LANDY M, PILLEMER L.
    J Exp Med; 1956 Jun 01; 103(6):823-33. PubMed ID: 13319594
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Fibrinolysis and factors of aspecific immunity. Preliminary note].
    Ferrauto A, Giuffrida G, Terranova R.
    Boll Soc Ital Biol Sper; 1965 Dec 31; 41(24):1488-91. PubMed ID: 5878160
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB, REYN A.
    Acta Pathol Microbiol Scand; 1959 Dec 31; 47():419-28. PubMed ID: 14414557
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB, REYN A.
    Acta Pathol Microbiol Scand; 1959 Dec 31; 47():405-18. PubMed ID: 14414558
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL, HASSIRDJIAN A, OSBORNE W, BUNN PA.
    J Lab Clin Med; 1961 Mar 31; 57():420-7. PubMed ID: 13686461
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.